Financing Round

Arthrosi’s gout drug financed with $75 million Series D

13-Jul-2023 By Jonathan Smith

The U.S. company Arthrosi Therapeutics has bagged $75 million in a Series D round to fund the clinical development of a small molecule drug for chronic gout.

German smartbax closes seed financing of €1.2M for 'new solutions against multi-drug resistant pathogens'

23-May-2023 By Liza Laws

A biotech advancing small molecule antibiotics through preclinical studies has closed its seed financing round of €1.2million ($1.3million) from Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds (HTGF).

$14m raised in Series B will continue expansion of Experic’s headquarters

05-Dec-2022 By Maggie Lynch

Experic raises $14m in series B led by Harro Hofilger Packaging Systems and East Seattle Partners as CDMO sees growth in DPI product and clinical trial supply needs.

Vial secures $67m in funding for biotech-focused CRO

05-Dec-2022 By Ben Hargreaves

The CRO focuses its services towards biotechs by stating that they are cheaper and more efficient compared to rivals, and it was this principle that drew in General Catalyst to provide investment.

Will biotech see an uptick in M&A?

19-Jul-2022 By Rachel Arthur

The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?